Opus Genetics IRD Unpaid Series B preferred stock issuance costs
Unpaid Series B preferred stock issuance costs at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept ird:UnpaidIssuanceCosts.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's unpaid series b preferred stock issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's unpaid series b preferred stock issuance costs?
- Opus Genetics (IRD) reported unpaid series b preferred stock issuance costs of $111K in Q1 2026.
- What does unpaid series b preferred stock issuance costs mean?
- Represents costs associated with the issuance of equity or debt securities that have been incurred but not yet settled in cash. This metric provides insight into outstanding financial obligations related to capital-raising activities that will impact future cash flows.